NCT04093570: A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- State
- Under way
- Phase
- Phase 2
- People
- 332 planned
- Started
- 30 Sep 2019
- Primary completion
- 31 Dec 2027
- Arms
- Main Extension Study: ASTX727, Substudy Arm A: ASTX727 With High-Calorie/High-Fat Breakfast Meal on Day 4, Substudy Arm B: ASTX727 With Low-Calorie/Low-Fat Breakfast Meal on Day 4
- Results
- None posted
- 18 Sep 2019: Trial registered
- 30 Sep 2019: Trial started